Abstract:Objective: Nasopharyngeal carcinoma (NPC) is one of the dominant cancers in South China and Taiwan. Although NPC is highly chemosensitive, the use of chemotherapy for treating patients with recurrent or metastatic NPC has not been very successful. The emergence of drug resistance may be one of the major reasons. However, the mechanisms of drug resistance of NPC have never been addressed before. In this study, we sought to clarify the role of classical drug resistance markers in predicting the chemosensitivity and the prognosis of patients with advanced NPC. Methods: In a cohort of 202 consecutive patients diagnosed at the Department of Pathology of the National Taiwan University Hospital, 44 patients with adequately preserved pretreatment tumor tissues and complete clinical information regarding the details of chemotherapy and tumor response were identified. The expression of multidrug resistance (MDR1), glutathione-S-transferase-pi (GSTpi), and p53 were determined by immunohistochemistry. Tumor response to chemotherapy and survival of the patients were the end-points of this analysis. Results: Thirty-four patients received cisplatin-based regimens, and 28 of them were enrolled in a prospective trial using a doxorubicin-containing regimen. The overall response rate was 70%. Expression of MDR1 was seen in only 5 cases (11%) and was associated with a significantly worse overall survival, yet did not appear to predict chemoresistance to the doxorubicin-containing regimen. Overexpression of p53 was seen in 22 patients, and surprisingly, was correlated with chemoresponse and a trend towards better survival. GSTpi expression was demonstrated in 13 cases (30%) and was not correlated with chemoresistance to cisplatin-containing regimens and overall survival. Conclusion: In this relatively small cohort, positive MDR1 immunostaining predicted a poor overall survival for recurrent or metastatic NPC patients receiving chemotherapy. Overexpression of p53 by immunohistochemical staining, however, was associated with a better response rate to systemic chemotherapy and a trend towards better survival. Copyright (C) 2002 S. Karger AG, Basel.

Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma

Identification of Prognostic Biomarkers for Response to Radiotherapy by DNA Microarray in Nasopharyngeal Carcinoma Patients

Expression of vascular endothelial growth factor and C-erb B-2 as prognostic factors in nasopharyngeal carcinoma

Immunohistochemical expression of epidermal growth factor receptor and cyclooxygenase-2 in pediatric nasopharyngeal carcinomas: no significant correlations with clinicopathological variables and treatment outcomes

P53, MDM2, Eif4e and EGFR Expression in Nasopharyngeal Carcinoma and Their Correlation with Clinicopathological Characteristics and Prognosis: A Retrospective Study

Prognostic value of multidrug resistance 1, glutathione-S-transferase-pi and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy.

Relationship Between Cyclooxygenase-2 (COX-2) Content and Prognosis in Nasopharyngeal Carcinoma Before and after Radiochemotherapy.

Epression and Significance of VEGF-C,COX-2 and VEGFR-3 in Nasopharyngeal Carcinoma

The Prognostic Value of COX-2 Expression on Circulating Tumor Cells in Nasopharyngeal Carcinoma: A Prospective Analysis.

Prognostic Analysis of Patients with Locally Advanced Nasopharyngeal Carcinoma Following Intensity Modulated Radiation Therapy.

[Significance of EGFR and P-Erk Expression in Nasopharyngeal Carcinoma].

Correlation of Epidermal Growth Factor Receptor Activation to Metastasis-free Survival of Nasopharyngeal Carcinoma Patients

[Expressions of Cyclooxygenase-2 and Basic Fibroblast Growth Factor in Nasopharyngeal Carcinoma and Their Association with Radiotherapy Sensitivity].

Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma

Value of COX-2,VEGF and EGFR Expressions in Predicting Prognosis for Nasopharyngeal Carcinoma

[Expression Clinical Significance of Nm23-H1 and Vessel Endothelium Growth Factor Protein in Nasopharyngeal Carcinoma].

Expression and clinical significance of PD-L1 and BRAF expression in nasopharyngeal carcinoma

Multivariate analysis of prognostic makers in patients with nasopharyngeal carcinoma intreatment of radiotherapy combined with induction chemotherapy]

Cyclooxygenase-2 Expression is Positively Associated with Lymph Node Metastasis in Nasopharyngeal Carcinoma

PET/CT standardized uptake value and EGFR expression predicts treatment failure in nasopharyngeal carcinoma

Prospective Validation of the Prognostic Value of Elevated Serum Vascular Endothelial Growth Factor in Patients with Nasopharyngeal Carcinoma: More Distant Metastases and Shorter Overall Survival after Treatment